Country Market Access and Pricing Senior Director, Access Strategy Amlitelimab

Job Title: Country Market Access and Pricing Senior Director, Access Strategy Amlitelimab

Location: Cambridge, MA

About the Job

The Sr. Director of Access Strategy, amlitelimab is responsible for integrating at a strategy and execution level all elements of access for a particular brand or franchise inclusive of pricing/contracting strategy and GTN management, channel strategy, patient copay and other patient services related to coverage, reimbursement and patient access. responsible for defining, developing and leading the market access strategy for the therapeutic area. Reporting directly to the General Manager, US Therapeutic Area, or equivalent for pre-launched assets, this role will act as a thought partner and consultant by presenting scope analysis, strategic options and recommendations ensuring the strategy for formulary access and financial objectives (revenue, net sales, BOI) are overdelivering for the portfolio of innovative therapies. This highly visible role must provide a holistic understanding of both brand and access strategy.

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities:

Access Strategy & Market Access Excellence:

• Collaborate with the General Manager & senior leadership to set strategic direction for market access, pricing, channel strategy, and reimbursement.

• Develop and execute a robust, evidence-based market access strategy that maximizes payer adoption and patient access to critical therapies.

• Lead the creation of value propositions that demonstrate the economic and clinical benefits of products to payers, healthcare providers, and stakeholders.

• Develop and communicate robust market access strategies and plans, including clear articulation of the brands’ value story, and help to integrate them into the overall brand plan.

• Partner with HEVA business partners to inform real world evidence generation and ensure health economic activities are in place to meet the needs of payers.

• Lead efforts to anticipate and adapt to changes in the regulatory and reimbursement landscape, ensuring compliance and sustained market access.

• Identify gaps in current market access understanding and develop plans to gain direct payer insights through primary research, advisory boards, etc., and work with vendors to implement projects in a timely, impactful manner.

• Lead pull through opportunities and execution of pull through strategy for all channels and geographies based upon formulary position and opportunity.

• Provide strategic and executional support for product launches, including market research, pricing strategy, contracting, and messaging to ensure successful market entry and adoption.

Gross-to-Net (GTN) Strategy & Financial Oversight:

• Oversee and optimize the GTN for the therapeutic area, ensuring that pricing, rebates, and discounts [by channel] are managed efficiently to optimize net sales / BOI.

• Monitor and analyze GTN performance, providing recommendations to senior leadership to mitigate risks and maximize profitability.

• Work closely with Market Access Shared Services, Finance, Forecasting, Patient Support Services, Trade, Legal, and other cross functional stakeholders to identify opportunities to improve the brand gross-to-net while ensuring ease of access for patients at dispense.

• Works directly to develop external stakeholder engagement plans (payers, PBMs)

• As part of GTN management, ensuring success at all payers as well as the deployment of thoughtful copay programs will be a key focus.  Partnering with these key functions [Trade, Patient Support Services] will be essential in the overall success of the therapeutic area.

• Develop key performance indi